Europe Cold and Flu Supplements Market Trends, Size, Competitive Analysis and Forecast 2020-2026


Posted September 21, 2020 by mansi3210

Europe Cold and Flu Supplements Market Size, Share & Trends Analysis Report by Product Type , and Forecast 2020-2026
 
The European cold and flu supplements market is anticipated to grow at a CAGR of 6.2% during the forecast period (2020-2026). The growth of the market will be majorly driven by the increasing adoption of natural supplements across the region. Additionally, the side effects of various over the counter drugs such as drowsiness is also encouraging the adoption of supplement across the region for the treatment and prevention of cold and flu. This, in turn, will drive the growth of the cold and flu supplement industry across Europe.

Request a Free Sample of our Europe Cold and Flu Supplements Market: https://www.omrglobal.com/request-sample/europe-cold-and-flu-supplements-market

Furthermore, the high popularity of elderberry across the region as a natural remedy to aid with the sickness and speed up recovery of cold and flu conditions is impacting the growth of the cold and flu market. Various lab studies have indicated that extracts of European elderberry work in two ways by blocking the ability of various flu viruses to replicated by activating an immune response to fight the virus in cells that have already been infected. Moreover, various supplements that combine Vitamin C, Zinc, and elderberries together, to improve its action against the flu virus are widely available being offered by the manufacturers across the region. This is also expected to significantly fuel the growth of the the cold and flu supplement market during the forecast period.

A full Report of Europe Cold and Flu Supplements Market is Available at: https://www.omrglobal.com/industry-reports/europe-cold-and-flu-supplements-market

Market Coverage
• Market numbers available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered-
o By Product Type
• CountriesCovered-
o United Kingdom
o Germany
o Italy
o Spain
o France
o Rest of Europe
• Competitive Landscape-Amway Corp., Ezyleaf Nutrition, GlaxoSmithKline plc, andVitabiotics Ltd.

Key Questions Addressed by the Report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

European Cold and Flu Supplements Market Report Segment

By Product Type

• Natural Molecules
• Herbal Extracts
• Vitamins & Minerals

European Cold and Flu Supplements Market Regional

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Company Profiles

• Amway Corp.
• Ezyleaf Nutrition
• GlaxoSmithKline plc
• Holland & Barrett Retail Ltd.
• mcePharma s. r. o.
• Nutraceuticals Group Europe Ltd.
• Sirio Pharma Co., Ltd.
• Vitabiotics Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-cold-and-flu-supplements-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mansi Jain
Phone +91 7803040404
Country India
Categories Business , Food , Health
Tags market analysis , market forecast , market research , nutraceuticals functional foods
Last Updated September 21, 2020